Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
06/26/2023
Jolynn Tumolo
“PD patients as well as health care providers were in general positive about using wearable sensors to improve PD care and self-management,” researchers wrote, “although the specific context and expected benefits varied considerably between...
“PD patients as well as health care providers were in general positive about using wearable sensors to improve PD care and self-management,” researchers wrote, “although the specific context and expected benefits varied considerably between...
“PD patients as well as health...
06/26/2023
Annals of Long-Term Care
News
06/23/2023
Jolynn Tumolo
Researchers studied the efficacy and tolerability of obinutuzumab plus bendamustine in patients with relapsed/refractory chronic lymphocytic leukemia.
Researchers studied the efficacy and tolerability of obinutuzumab plus bendamustine in patients with relapsed/refractory chronic lymphocytic leukemia.
Researchers studied the efficacy...
06/23/2023
First Report Managed Care
News
06/23/2023
Jolynn Tumolo
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that...
06/23/2023
First Report Managed Care
News
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network
News
06/23/2023
Jolynn Tumolo
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two...
06/23/2023
Pharmacy Learning Network
News
06/22/2023
Jolynn Tumolo
For the study, patients who were heavily pretreated for chronic lymphocytic leukemia received ceralasertib with vs without acalabrutinib.
For the study, patients who were heavily pretreated for chronic lymphocytic leukemia received ceralasertib with vs without acalabrutinib.
For the study, patients who were...
06/22/2023
First Report Managed Care
News
06/21/2023
Jolynn Tumolo
Infection prevention and vaccination of high-risk adults may mitigate increased care needs for health care-associated respiratory syncytial virus, researchers said. 
Infection prevention and vaccination of high-risk adults may mitigate increased care needs for health care-associated respiratory syncytial virus, researchers said. 
Infection prevention and...
06/21/2023
Pharmacy Learning Network
News
06/19/2023
Jolynn Tumolo
This study demonstrated minimal radiographic progression and sustained reduction in sacroiliac joint inflammation with secukinumab administered over 2 years for patients with NrAxSpa.
This study demonstrated minimal radiographic progression and sustained reduction in sacroiliac joint inflammation with secukinumab administered over 2 years for patients with NrAxSpa.
This study demonstrated minimal...
06/19/2023
First Report Managed Care
News
06/16/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been...
06/16/2023
Pharmacy Learning Network